Payment overview · 2025
General Payments
$30.22
2 reported records · 2 companies
Healthcare provider profile · identity verified
Aleksandra Dukhan
Allopathic & Osteopathic Physicians|Family Medicine · SAN ANTONIO, TX · NPI 1164982450
Verified facts
What the public records show
CMS Open Payments records show Aleksandra Dukhan received $30.22 in general payments during 2025 across 2 reported records.
Merck Sharp & Dohme LLC accounted for 54.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $16.59 | 54.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $13.63 | 45.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $30.22 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $16.59 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $16.59 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $13.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 637 | 231 |
| Levothyroxine Sodium | Levothyroxine Sodium | 437 | 144 |
| Metformin Hcl | Metformin Hcl | 402 | 151 |
| Amlodipine Besylate | Amlodipine Besylate | 321 | 120 |
| Losartan Potassium | Losartan Potassium | 299 | 121 |
| Lisinopril | Lisinopril | 290 | 110 |
| Fluticasone Propionate | Fluticasone Propionate | 279 | 150 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 247 | 93 |
| Omeprazole | Omeprazole | 214 | 85 |
| Alendronate Sodium | Alendronate Sodium | 205 | 76 |
| Gabapentin | Gabapentin | 192 | 84 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 191 | 80 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 175 | 175 |
| Hydrochlorothiazide | Hydrochlorothiazide | 173 | 67 |
| Ozempic | Semaglutide | 153 | 34 |
| Tramadol Hcl | Tramadol Hcl | 146 | 57 |
| Montelukast Sodium | Montelukast Sodium | 141 | 52 |
| Jardiance | Empagliflozin | 140 | 57 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 135 | 39 |
| Trazodone Hcl | Trazodone Hcl | 129 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 127 | 47 |
| Tamsulosin Hcl | Tamsulosin Hcl | 123 | 45 |
| Trulicity | Dulaglutide | 118 | 30 |
| Carvedilol | Carvedilol | 116 | 45 |
| Simvastatin | Simvastatin | 114 | 42 |
| Januvia | Sitagliptin Phosphate | 113 | 39 |
| Furosemide | Furosemide | 112 | 55 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 109 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 108 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 107 | 44 |
| Ciclopirox | Ciclopirox | 105 | 64 |
| Glipizide | Glipizide | 91 | 31 |
| Eliquis | Apixaban | 87 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 83 | 38 |
| Sertraline Hcl | Sertraline Hcl | 82 | 37 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 76 | 63 |
| Glipizide Er | Glipizide | 71 | 26 |
| Nifedipine Er | Nifedipine | 71 | 34 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 71 | 60 |
| Duloxetine Hcl | Duloxetine Hcl | 65 | 21 |
| Famotidine | Famotidine | 64 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 64 | 31 |
| Glimepiride | Glimepiride | 61 | 25 |
| Prednisone | Prednisone | 61 | 51 |
| Donepezil Hcl | Donepezil Hcl | 60 | 27 |
| Metformin Hcl Er | Metformin Hcl | 58 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 55 | 20 |
| Meloxicam | Meloxicam | 55 | 32 |
| Mounjaro | Tirzepatide | 55 | 17 |
| Enalapril Maleate | Enalapril Maleate | 52 | 22 |
| Fenofibrate | Fenofibrate | 48 | 17 |
| Memantine Hcl | Memantine Hcl | 47 | 19 |
| Myrbetriq | Mirabegron | 47 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | 16 |
| Ramipril | Ramipril | 46 | 16 |
| Farxiga | Dapagliflozin Propanediol | 45 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | 17 |
| Alprazolam | Alprazolam | 43 | 19 |
| Finasteride | Finasteride | 41 | 18 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 40 | 16 |
| Azithromycin | Azithromycin | 37 | 36 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 13 |
| Spironolactone | Spironolactone | 36 | suppressed |
| Pregabalin | Pregabalin | 35 | 20 |
| Azelastine Hcl | Azelastine Hcl | 34 | 27 |
| Mirtazapine | Mirtazapine | 34 | 14 |
| Buspirone Hcl | Buspirone Hcl | 33 | 11 |
| Celecoxib | Celecoxib | 33 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 30 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Ezetimibe | Ezetimibe | 30 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | 12 |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 30 | 13 |
| Naproxen | Naproxen | 29 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | 11 |
| Meclizine Hcl | Meclizine Hcl | 28 | 21 |
| Clonazepam | Clonazepam | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 26 |
| Diclofenac Sodium | Diclofenac Sodium | 26 | 18 |
| Potassium Chloride | Potassium Chloride | 26 | 13 |
| Allopurinol | Allopurinol | 25 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 25 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Nystatin | Nystatin | 24 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 23 |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 22 | 18 |
| Ibuprofen | Ibuprofen | 22 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Lorazepam | Lorazepam | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 20 | suppressed |
| Fluconazole | Fluconazole | 19 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 18 | 12 |
| Bydureon Bcise | Exenatide Microspheres | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Folic Acid | Folic Acid | 17 | suppressed |
| Incontrol Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 16 |
| Nitroglycerin | Nitroglycerin | 17 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | suppressed |
| Atenolol | Atenolol | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 14 |
| Clotrimazole | Clotrimazole | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Jantoven | Warfarin Sodium | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Ramelteon | Ramelteon | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Prolia | Denosumab | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $30.22 · 2 records | Merck Sharp & Dohme LLC | CAPVAXIVE, GARDASIL 9, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error